BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND Cytokeratin fragment 21-1 AND Diagnosis
8 results:

  • 1. IR808@MnO nano-near infrared fluorescent dye's diagnostic value for malignant pleural effusion.
    Wang X; Yan X; Zhang Z; Xu C; Du F; Xie Y; Yin X; Lei Z; Jiang Y; Yang W; Zhou X; Wang Y
    Respir Res; 2024 Jan; 25(1):22. PubMed ID: 38195540
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Plasmonic metasurface enhanced by nanobumps for label-free biosensing of lung tumor markers in serum.
    Wang Z; Chen W; Liu X; Lin S; Deng B; Shen J; Li F; Zhu J
    Talanta; 2023 Nov; 264():124731. PubMed ID: 37285700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Recent progress of biosensors for the detection of lung cancer markers.
    Chen S; Li M; Weng T; Wang D; Geng J
    J Mater Chem B; 2023 Jun; 11(25):5715-5747. PubMed ID: 37264815
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancer.
    Luo Y; Zhang Q; Lv B; Shang Y; Li J; Yang L; Yu Z; Luo K; Deng X; Min L; Zhu T
    Int J Biol Markers; 2022 Mar; 37(1):58-65. PubMed ID: 35072545
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer.
    Ajona D; Remirez A; Sainz C; Bertolo C; Gonzalez A; Varo N; Lozano MD; Zulueta JJ; Mesa-Guzman M; C Martin A; Perez-Palacios R; Perez-Gracia JL; Massion PP; Montuenga LM; Pio R
    Transl Res; 2021 Jul; 233():77-91. PubMed ID: 33618009
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Optimal cut-off values for CYFRA 21-1 expression in NSCLC patients depend on the presence of benign pulmonary diseases.
    Xu RH; Liao CZ; Luo Y; Xu WL; Li K; Chen JX; Huang YF; Chen YC; Zhu L; Yuan WB
    Clin Chim Acta; 2015 Feb; 440():188-92. PubMed ID: 25304744
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical significance of serum transforming growth factor-β1 in lung cancer.
    Hou YL; Chen H; Dong ZH; Xue CJ; Wu YF; Luo HX; Wu YC; Li CH
    Cancer Epidemiol; 2013 Oct; 37(5):750-3. PubMed ID: 23727122
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.